Vitura Health (ASX:VIT) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

VIT 주식 개요

Vitura Health Limited는 호주와 아시아에서 약용 대마초 제품을 판매 및 유통하는 회사입니다.

VIT 기본 분석
눈송이 점수
가치 평가	4/6
미래 성장	0/6
과거 실적	3/6
재무 상태	6/6
배당금	4/6

보상

공정 가치 추정치보다 낮은 64.7% 에서 거래

위험 분석

최근 3개월간 주가 변동폭 심해

지난 1년 동안 주주가 희석되었습니다.

지난 3개월간 상당한 내부자 매도

불안정한 배당 실적

+ 1 더 많은 위험

Vitura Health Limited 경쟁사

ECS Botanics Holdings

ASX:ECS

AU$21.9m

Vita Life Sciences

ASX:VLS

AU$128.4m

EZZ Life Science Holdings

ASX:EZZ

AU$81.9m

Neuren Pharmaceuticals

ASX:NEU

AU$2.7b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Vitura Health
과거 주가
현재 주가	AU$0.086
52주 최고치	AU$0.60
52주 최저치	AU$0.075
베타	0.18
11개월 변경	13.16%
3개월 변경 사항	-54.74%
1년 변경 사항	-83.30%
33년 변화	-21.82%
5년 변화	n/a
IPO 이후 변화	-74.71%

최근 뉴스 및 업데이트

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Apr 25

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11

Recent updates

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Apr 25

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Dec 13

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Nov 01

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Jul 18

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Sep 12

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Sep 05

주주 수익률

	VIT	AU Pharmaceuticals	AU 마켓
7D	-8.5%	6.5%	-0.3%
1Y	-83.3%	71.6%	8.3%

수익률 대 산업: VIT 지난 1년 동안 64.4 %를 반환한 Australian Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: VIT 지난 1년 동안 6.7 %를 반환한 Australian 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is VIT's price volatile compared to industry and market?
VIT volatility
VIT Average Weekly Movement	16.9%
Pharmaceuticals Industry Average Movement	9.8%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

안정적인 주가: VIT 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: VIT 의 주간 변동성( 17% )은 지난 1년 동안 안정적이었지만 여전히 Australian 의 75%보다 높습니다. 주식.

회사 소개

설립	직원	CEO	웹사이트
2018	n/a	Tom Howitt	vitura.com.au

Vitura Health Limited는 호주와 아시아에서 약용 대마초 제품의 판매 및 유통을 담당하고 있습니다. 이 회사는 약용 대마초의 처방, 조제 및 약물 관리 솔루션을 제공하는 온라인 플랫폼인 CanView, 약용 대마초 상담 및 처방 서비스를 제공하는 CDA Clinics, 원격 의료 상담을 제공하는 약용 대마초 클리닉인 Cannadoc을 운영하고 있습니다. 또한 Cortexa 브랜드로 환각제를, Adaya 브랜드로 중쇄중성지방 오일 및 전체 꽃 제품과 같은 식물 기반 의약품을 제공합니다.

Vitura Health Limited 기본 사항 요약

Vitura Health 의 수익과 매출은 시가총액과 어떻게 비교하나요?
VIT 기본 통계
시가총액	AU$49.53m
수익(TTM)	AU$9.40m
수익(TTM)	AU$119.66m

5.3x

P/E 비율

0.4x

P/S 비율

VIT 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
VIT 손익 계산서(TTM)
수익	AU$119.66m
수익 비용	AU$81.81m
총 이익	AU$37.85m
기타 비용	AU$28.45m
수익	AU$9.40m

최근 보고된 수익

Dec 31, 2023

다음 수익 날짜

n/a

주당 순이익(EPS)	0.016
총 마진	31.63%
순이익 마진	7.86%
부채/자본 비율	15.9%

VIT 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

11.6%

현재 배당 수익률

60%

지급 비율

VIT 주식 개요

보상

위험 분석

Vitura Health Limited 경쟁사

ASX:ECS

AU$21.9m

ASX:VLS

AU$128.4m

ASX:EZZ

AU$81.9m

ASX:NEU

AU$2.7b

가격 내역 및 성능

최근 뉴스 및 업데이트

Less than half of directors are independent

Board Member recently sold AU$1.1m worth of stock

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

New major risk - Share price stability

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

First half 2024 earnings released: EPS: AU$0.006 (vs AU$0.014 in 1H 2023)

Recent updates

Less than half of directors are independent

Board Member recently sold AU$1.1m worth of stock

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

New major risk - Share price stability

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

First half 2024 earnings released: EPS: AU$0.006 (vs AU$0.014 in 1H 2023)

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Now 39% undervalued after recent price drop

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Vitura Health Limited Receives Shareholder Requisition from Elizabeth Sarah Jansen

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Vitura Health Limited (ASX:VIT) completed the acquisition of acquire an unknown stake in Doctors on Demand from Yeates Ventures Pty Ltd and Kirsty Garrett.

New minor risk - Shareholder dilution

Vitura Health Limited, Annual General Meeting, Nov 28, 2023

Upcoming dividend of AU$0.01 per share at 2.7% yield

Vitura Health Limited Announces Dividend for the Year Ended 30 June 2023, Payable on or Around, 28 September 2023

New major risk - Earnings quality

New minor risk - Financial data availability

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Insider recently sold AU$2.3m worth of stock

New minor risk - Share price stability

Chief Commercial Officer recently sold AU$5.9m worth of stock

High number of new and inexperienced directors

Cronos Australia Limited Announces Changes to Clinical Operations

High number of new and inexperienced directors

High number of new and inexperienced directors

Cronos Australia Limited Announces Board Changes

High number of new and inexperienced directors

High number of new and inexperienced directors

Cronos Australia Limited Announces Ceases of Benjamin D.N. Jansen as Chief Medical Officer

Cronos Australia Limited Provides Update on Canview 2.0 Platform

Cronos Australia Limited, Annual General Meeting, Nov 29, 2022

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Cronos Australia Limited Appoints Jenelle Frewen and Simone Scovell as Independent Non-Executive Director

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Cronos Australia Limited Announces Dividend for the Year Ended 30 June 2022, Dividend Payment Date Is 11 October 2022

Full year 2022 earnings released: EPS: AU$0.013 (vs AU$0.031 loss in FY 2021)

Cronos Australia Limited to Report Q2, 2022 Results on Jul 27, 2022

Cronos Australia Announces Resignation of Shane Tanner, Chairman and Director

Cronos Australia Limited Announces Resignation of Kurt Thomas Schmidt as Director

First half 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Cronos Australia Limited (ASX:CAU) completed the acquisition of Cannabis Doctors Australia Pty Ltd.

Cronos Australia Limited (ASX:CAU) entered into Merger implementation agreement to acquire Cannabis Doctors Australia Pty Ltd.

Cronos Australia Limited Announces Launch of Additional Products in Key Asian Markets

Cronos Australia Limited Provides Revenue Guidance for the Fourth Quarter of 2021

Cronos Australia Limited Announces Launch of First Personal Care Brand in North Asian Markets with Bathing Shed

주주 수익률

가격 변동성

회사 소개

Vitura Health Limited 기본 사항 요약

5.3x

0.4x

수익 및 수익

배당금

11.6%

60%